Lead Paragraph
Stryker announced on April 13, 2026, that it has agreed to acquire Amplitude Vascular Systems, a firm specializing in intravascular lithotripsy technology. The terms of the acquisition were not disclosed.
Details
Amplitude Vascular Systems, based in Boston, uses carbon dioxide to generate pressure waves through a balloon catheter to break up calcified plaque in arteries. The acquisition is anticipated to enhance Stryker’s peripheral vascular portfolio once AVS’ device receives clearance in key markets.
Company Background
Stryker, a global medical technology company, is known for its innovative products in orthopedics, medical and surgical, and neurotechnology and spinal fields. Founded in 1941 and headquartered in Michigan, Stryker has a long-standing commitment to improving patient and hospital outcomes.
Market Context
This acquisition highlights Stryker’s strategic move to expand its presence in the cardiovascular procedure sector, recognizing intravascular lithotripsy as a rapidly growing field. The move is in line with the company’s vision to offer advanced solutions for treating artery disease, potentially positioning AVS’s technology as a significant challenger in the market.
If you are exploring product design and medical device engineering, BangDesign has relevant experience.
Source: MedTech Dive